Abstract: Mutation testing is an effective test adequacy assessment technique. However, there is a high computational cost in executing the test suite against a potentially large pool of generated ...
Syntax Bio expands Series A to $14.4M to boost CRISPR Cellgorithm platform and type 1 diabetes beta-cell therapy amid tough biotech funding—read more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results